retatrutide dosage phase 2 trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide peptide 20mg: complete dosing

Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

When you eat, []

As conversations around GLP-1 medications continue to grow, its important to reframe how we think about weight management

The semaglutide shortage could be lifted any day, according to data analysis of past shortages on archived FDA webpages and interviews with industry experts.

Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.

Liraglutide seems to have a positive effect on bone material properties despite significant weight loss in several rodent models